Gertrude Peterson

2.5k total citations
50 papers, 1.9k citations indexed

About

Gertrude Peterson is a scholar working on Reproductive Medicine, Surgery and Oncology. According to data from OpenAlex, Gertrude Peterson has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Reproductive Medicine, 23 papers in Surgery and 20 papers in Oncology. Recurrent topics in Gertrude Peterson's work include Ovarian cancer diagnosis and treatment (25 papers), Intraperitoneal and Appendiceal Malignancies (18 papers) and Chemotherapy-related skin toxicity (15 papers). Gertrude Peterson is often cited by papers focused on Ovarian cancer diagnosis and treatment (25 papers), Intraperitoneal and Appendiceal Malignancies (18 papers) and Chemotherapy-related skin toxicity (15 papers). Gertrude Peterson collaborates with scholars based in United States. Gertrude Peterson's co-authors include Jerome L. Belinson, Barbara Kulp, Maurie Markman, Kenneth Webster, Alexander Kennedy, Kristine Zanotti, Maurie Markman, Paul Elson, Lisa Rybicki and Keith A. Webster and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

Gertrude Peterson

50 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gertrude Peterson United States 23 833 671 581 571 428 50 1.9k
Barbara Kulp United States 20 746 0.9× 582 0.9× 474 0.8× 530 0.9× 355 0.8× 37 1.7k
Suzanne Berlin United States 15 451 0.5× 408 0.6× 378 0.7× 119 0.2× 143 0.3× 37 1.3k
Laurence Gladieff France 24 657 0.8× 752 1.1× 33 0.1× 531 0.9× 112 0.3× 135 1.9k
A Fanucchi Italy 24 833 1.0× 420 0.6× 49 0.1× 390 0.7× 28 0.1× 64 1.6k
Andreas du Bois Germany 9 1.5k 1.8× 827 1.2× 45 0.1× 819 1.4× 45 0.1× 18 2.1k
H. Curé France 22 256 0.3× 1.2k 1.8× 29 0.0× 367 0.6× 106 0.2× 82 2.0k
Giuseppe Roberto D’Agostino Italy 30 350 0.4× 669 1.0× 51 0.1× 607 1.1× 23 0.1× 125 2.4k
Sung Whan Ha South Korea 29 113 0.1× 892 1.3× 44 0.1× 636 1.1× 102 0.2× 126 2.1k
Bonnie Reichman United States 29 1.7k 2.0× 1.7k 2.5× 23 0.0× 1.7k 3.0× 122 0.3× 69 3.4k
Samuel S. Lentz United States 26 1.8k 2.1× 712 1.1× 35 0.1× 1.5k 2.6× 45 0.1× 60 3.8k

Countries citing papers authored by Gertrude Peterson

Since Specialization
Citations

This map shows the geographic impact of Gertrude Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gertrude Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gertrude Peterson more than expected).

Fields of papers citing papers by Gertrude Peterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gertrude Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gertrude Peterson. The network helps show where Gertrude Peterson may publish in the future.

Co-authorship network of co-authors of Gertrude Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of Gertrude Peterson. A scholar is included among the top collaborators of Gertrude Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gertrude Peterson. Gertrude Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markman, Maurie, Fred H. Hsieh, Kristine Zanotti, et al.. (2004). Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions. Journal of Cancer Research and Clinical Oncology. 130(1). 25–28. 41 indexed citations
2.
Peterson, Gertrude, et al.. (2004). Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers. Journal of Clinical Oncology. 22(14_suppl). 5080–5080. 1 indexed citations
3.
Markman, Maurie, Kenneth Webster, Kristine Zanotti, et al.. (2004). Phase 2 trial of carboplatin plus tamoxifen in platinum-resistant ovarian cancer and primary carcinoma of the peritoneum. Gynecologic Oncology. 94(2). 404–408. 18 indexed citations
4.
Markman, Maurie, Kenneth Webster, Kristine Zanotti, et al.. (2004). Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers. Journal of Cancer Research and Clinical Oncology. 130(12). 741–744. 3 indexed citations
5.
Markman, Maurie, Kenneth Webster, Kristine Zanotti, et al.. (2004). Phase 2 trial of prolonged administration of oral topotecan in platinum/taxane-refractory ovarian, fallopian tube, and primary peritoneal cancers. Gynecologic Oncology. 95(1). 109–113. 7 indexed citations
6.
Zanotti, Kristine, Kenneth Webster, Jerome L. Belinson, et al.. (2003). Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy. Gynecologic Oncology. 92(2). 592–595. 9 indexed citations
7.
Zanotti, Kristine, et al.. (2003). Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity. Gynecologic Oncology. 89(3). 514–516. 48 indexed citations
8.
Markman, Maurie, Barbara Kulp, Gertrude Peterson, Alexander Kennedy, & Jerome L. Belinson. (2002). Second-Line Therapy of Ovarian Cancer with Paclitaxel Administered by Both the Intravenous and Intraperitoneal Routes: Rationale and Case Reports. Gynecologic Oncology. 86(1). 95–98. 5 indexed citations
9.
Peterson, Gertrude, et al.. (2002). Effectiveness of Serotonin-Receptor Antagonist Antiemetic Therapy over Successive Courses of Carboplatin-Based Chemotherapy. Gynecologic Oncology. 85(3). 435–437. 3 indexed citations
10.
Markman, Maurie, Alexander Kennedy, Kenneth Webster, et al.. (2001). Combination Chemotherapy With Carboplatin and Docetaxel in the Treatment of Cancers of the Ovary and Fallopian Tube and Primary Carcinoma of the Peritoneum. Journal of Clinical Oncology. 19(7). 1901–1905. 72 indexed citations
11.
12.
13.
Markman, Maurie, Alexander Kennedy, Kenneth Webster, et al.. (2000). Declining CA-125 in an Ovarian Cancer Patient with Progression of Measurable Disease: A Rational Hypothesis for Discordant Results. Gynecologic Oncology. 77(2). 321–322. 6 indexed citations
14.
Kennedy, Alexander, et al.. (2000). Phase I trial of paclitaxel plus megestrol acetate in patients with paclitaxel-refractory ovarian cancer.. PubMed. 6(11). 4201–4. 7 indexed citations
15.
Markman, Maurie, Alexander Kennedy, Kenneth Webster, et al.. (1999). An effective and more convenient drug regimen for prophylaxis gainst paclitaxel-associated hypersensitivity reactions. Journal of Cancer Research and Clinical Oncology. 125(7). 427–429. 54 indexed citations
16.
Markman, Maurie, Alexander Kennedy, Kenneth Webster, et al.. (1999). Use of Low-Dose Oral Prednisone to Prevent Paclitaxel-Induced Arthralgias and Myalgias. Gynecologic Oncology. 72(1). 100–101. 37 indexed citations
17.
Markman, Maurie, Alexander Kennedy, Kenneth Webster, et al.. (1999). Persistent Chemosensitivity to Platinum and/or Paclitaxel in Metastatic Endometrial Cancer. Gynecologic Oncology. 73(3). 422–423. 11 indexed citations
18.
Markman, Maurie, Alexander Kennedy, Kenneth Webster, et al.. (1998). Evidence that a "treatment-free interval of less than 6 months" does not equate with clinically defined platinum resistance in ovarian cancer or primary peritoneal carcinoma. Journal of Cancer Research and Clinical Oncology. 124(6). 326–328. 18 indexed citations
19.
Markman, Maurie, Alexander Kennedy, Kenneth Webster, et al.. (1997). Low-dose intravenous ondansetron (8 mg) plus dexamethasone: an effective regimen for the control of carboplatin-induced emesis. Journal of Cancer Research and Clinical Oncology. 123(4). 224–226. 7 indexed citations
20.
Markman, Maurie, Alexander Kennedy, Kenneth Webster, et al.. (1997). Continued Chemosensitivity to Cisplatin/Carboplatin in Ovarian Carcinoma Despite Treatment with Multiple Prior Platinum-Based Regimens. Gynecologic Oncology. 65(3). 434–436. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Kulp Breakdown of academic impact, for papers by Suzanne Berlin Breakdown of academic impact, for papers by Laurence Gladieff Breakdown of academic impact, for papers by A Fanucchi Breakdown of academic impact, for papers by Andreas du Bois Breakdown of academic impact, for papers by H. Curé Breakdown of academic impact, for papers by Giuseppe Roberto D’Agostino Breakdown of academic impact, for papers by Sung Whan Ha Breakdown of academic impact, for papers by Bonnie Reichman Breakdown of academic impact, for papers by Samuel S. Lentz
Rankless by CCL
2026